Abbott
https://www.abbott.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Abbott
Biolinq Aims To Transform Diabetic Glucose Monitoring With Needle-Free Patch
Biolinq’s CEO Rich Yang spoke to Medtech Insight about the company’s wearable patch in development, which uses tiny microsensors to measure, for now, glucose, with ample runway for additional indications down the line. If approved by the US FDA, the device would become the first of its kind to monitor glucose levels in diabetes patients not using insulin.
News We’re Watching: DMCA Judicial Review Upheld; Abbott’s Rio CGM Available OTC; J&J’s Velys Wins FDA UKA Expansion
This week, AdvaMed and MITA win appeal to prevent repair companies from hacking medical devices, the FDA cleared Abbott’s Libre Rio CGM for OTC sales, J&J MedTech wins expanded clearance for Velys knee medical robot, the FDA updates its AI program, Canary Speech secures $13m in series A funding and Xeltis won FDA approval for an IDE submission to begin enrolling patients for a pivotal study for aXess.
Abbott Receives FDA Approval For Esprit BTK Drug-Eluting Resorbable Scaffold
The US has greenlighted Abbott’s Esprit BTK System for treating patients with chronic limb-threatening ischemia below the knee, making it the first dissolvable stent to treat this condition. A Wells Fargo analyst sees a $500m US market opportunity for the implant, which will see limited release in late 2024.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
Company Information
- Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- Nutraceuticals
-
Medical Devices
- Diagnostic Equipment & Supplies
- Implantable Devices
- Monitoring Equipment & Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
-
- Abbott Diabetes Care, Inc.
- Abbott Laboratories
- Abbott Medical Optics
- Advanced Medical Optics, Inc.
- AMO Manufacturing USA, LLC
- Advanced Neuromodulation Systems
- AGA Medical Corporation
- Alere, Inc.
- Axis-Shield plc
- Binax, Inc.
- Biosite, Inc.
- CardioMEMS
- Cephea Valve Technologies
- CFR Pharmaceuticals S.A.
- Cholestech Corporation
- Domestic Formulations
- Endocardial Solutions, Inc.
- Endosense SA
- EP Medsystems
- Epicor Medical, Inc.
- Evalve Inc.
- Facet Biotech Corporation
- Fournier Pharma
- Free & Clear, Inc.
- Garden Hills
- Guidant Corporation Vascular Device Division
- Ibis Biosciences
- IDEV Technologies
- Innogenetics nv
- Inverness Medical Innovations Inc.
- Irvine Biomedical
- Kos Pharmaceuticals, Inc.
- MediGuide Inc.
- MediSense
- Nanostim
- Inc.
- Neuromed Inc.
- NeuroTherm Inc
- Northstar Neuroscience, Inc.
- OptiMedica Corporation
- Ostex International Inc.
- Pacesetter
- Piramal Healthcare Solutions
- Quest Medical, Inc.
- Radi Medical Systems AB
- Spinal Modulation, Inc.
- Solvay Pharmaceuticals, Inc. (Unimed Pharmaceuticals, Inc.)
- Spinal Concepts
- St. Jude Medical, Inc.
- Tendyne Holdings, Inc.
- TheraSense, Inc.
- Thoratec Corporation
- Topera, Inc.
- US Diagnostics (USD)
- Velocimed, Inc.
- Ventritex
- Veropharm
- Walk Vascular, LLC
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice